Gambaran Umum
SI-BONE, Inc., based in the United States, operates within the medical device industry, specializing primarily in innovative surgical treatments for the sacroiliac joint. The company is renowned for its development and commercialization of the iFuse Implant System, a minimally invasive surgical system designed to provide stabilization and fusion of the sacroiliac joint. This patented technology has significantly impacted the treatment of lower back pain associated with sacroiliac joint dysfunction, a common yet under-diagnosed condition. SI-BONE’s focus on clinical education and providing evidence-based solutions has positioned it as a leader in this specialized segment of orthopedic surgery, catering to a growing patient population seeking alternative solutions to chronic pain.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk SI-BONE, Inc. per 2025 Jun 30 adalah 185.26 MM.
- Nilai operating income untuk SI-BONE, Inc. per 2025 Jun 30 adalah -27.61 MM.
- Nilai net income untuk SI-BONE, Inc. per 2025 Jun 30 adalah -23.76 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 185.26 | -27.61 | -23.76 |
2025-03-31 | 176.60 | -30.68 | -26.55 |
2024-12-31 | 167.18 | -35.25 | -30.91 |
2024-09-30 | 157.03 | -42.26 | -37.40 |
2024-06-30 | 150.71 | -45.80 | -40.85 |
2024-03-31 | 144.04 | -47.68 | -43.12 |
2023-12-31 | 138.89 | -46.93 | -43.34 |
2023-09-30 | 131.98 | -45.72 | -43.53 |
2023-06-30 | 124.40 | -48.12 | -47.66 |
2023-03-31 | 116.68 | -54.03 | -54.97 |
2022-12-31 | 106.41 | -59.61 | -61.26 |
2022-09-30 | 99.69 | -62.25 | -64.56 |
2022-06-30 | 95.54 | -61.88 | -66.27 |
2022-03-31 | 92.15 | -56.96 | -61.74 |
2021-12-31 | 90.15 | -51.67 | -56.57 |
2021-09-30 | 87.07 | -45.61 | -51.07 |
2021-06-30 | 85.15 | -40.49 | -44.68 |
2021-03-31 | 77.01 | -38.26 | -43.17 |
2020-12-31 | 73.39 | -38.57 | -43.70 |
2020-09-30 | 71.05 | -38.48 | -43.82 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -0.75 | |
2024-09-30 | -0.91 | -0.91 |
2024-06-30 | -1.00 | -1.00 |
2024-03-31 | -1.08 | -1.08 |
2023-12-31 | -1.13 | |
2023-09-30 | -1.18 | -1.18 |
2023-06-30 | -1.34 | -1.34 |
2023-03-31 | -1.59 | -1.60 |
2022-12-31 | -1.79 | |
2022-09-30 | -1.90 | -1.90 |
2022-06-30 | -1.97 | -1.97 |
2022-03-31 | -1.85 | -1.85 |
2021-12-31 | -1.71 | |
2021-09-30 | -1.56 | -1.56 |
2021-06-30 | -1.42 | -1.42 |
2021-03-31 | -1.42 | -1.42 |
2020-12-31 | -1.50 | |
2020-09-30 | -1.60 | -1.60 |
2020-06-30 | -1.73 | -1.73 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk SI-BONE, Inc. per 2025 Jun 30 adalah -3.26 MM.
- Nilai cash from investing activities untuk SI-BONE, Inc. per 2025 Jun 30 adalah 9.27 MM.
- Nilai kas dari aktivitas pendanaan untuk SI-BONE, Inc. per 2025 Jun 30 adalah 2.41 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -3.26 | 9.27 | 2.41 |
2025-03-31 | -9.77 | 16.91 | 1.96 |
2024-12-31 | -12.43 | 12.62 | 1.96 |
2024-09-30 | -15.90 | -10.63 | 2.88 |
2024-06-30 | -18.27 | -69.27 | 2.49 |
2024-03-31 | -15.53 | -65.15 | 89.83 |
2023-12-31 | -18.71 | -59.80 | 90.93 |
2023-09-30 | -23.19 | -40.80 | 90.78 |
2023-06-30 | -27.64 | 22.80 | 91.13 |
2023-03-31 | -38.90 | 31.50 | 3.23 |
2022-12-31 | -41.66 | -2.81 | 2.20 |
2022-09-30 | -47.59 | 12.47 | 2.52 |
2022-06-30 | -50.38 | 30.50 | -3.13 |
2022-03-31 | -43.69 | 36.09 | -2.14 |
2021-12-31 | -39.53 | 51.58 | -1.71 |
2021-09-30 | -34.70 | -31.62 | 70.31 |
2021-06-30 | -30.94 | -63.53 | 76.32 |
2021-03-31 | -30.67 | -73.38 | 73.85 |
2020-12-31 | -30.66 | -62.92 | 136.40 |
2020-09-30 | -31.81 | 10.48 | 64.61 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 |
Efektivitas Manajemen
- roa untuk SI-BONE, Inc. pada 2025 Jun 30 adalah -0.12.
- roe untuk SI-BONE, Inc. pada 2025 Jun 30 adalah -0.14.
- roic untuk SI-BONE, Inc. pada 2025 Jun 30 adalah -0.13.
- croic untuk SI-BONE, Inc. pada 2025 Jun 30 adalah 0.04.
- ocroic untuk SI-BONE, Inc. pada 2025 Jun 30 adalah -0.05.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.12 | -0.14 | -0.13 | 0.04 | -0.05 |
2025-03-31 | -0.14 | -0.16 | -0.15 | 0.01 | -0.06 |
2024-12-31 | -0.16 | -0.18 | -0.18 | -0.11 | -0.08 |
2024-09-30 | -0.16 | -0.22 | -0.20 | -0.42 | -0.09 |
2024-06-30 | -0.29 | -0.46 | -0.21 | 0.04 | -0.08 |
2024-03-31 | -0.28 | -0.44 | -0.21 | 0.06 | -0.09 |
2023-12-31 | -0.28 | -0.42 | -0.20 | 0.13 | -0.11 |
2023-09-30 | -0.29 | -0.46 | -0.22 | 0.40 | -0.13 |
2023-06-30 | -0.33 | -0.46 | -0.22 | 0.40 | -0.13 |
2023-03-31 | -0.35 | -0.45 | -0.41 | -0.03 | -0.29 |
2022-12-31 | -0.33 | -0.45 | -0.45 | -0.24 | -0.33 |
2022-09-30 | -0.34 | -0.45 | -0.45 | -0.24 | -0.33 |
2022-06-30 | -0.30 | -0.43 | -0.46 | -0.17 | -0.35 |
2022-03-31 | -0.26 | -0.38 | -0.38 | -0.06 | -0.27 |
2021-12-31 | -0.23 | -0.33 | -0.32 | 0.06 | -0.19 |
2021-09-30 | -0.33 | -0.50 | -0.27 | 0.02 | -0.16 |
2021-06-30 | -0.28 | -0.41 | -0.23 | -0.09 | -0.16 |
2021-03-31 | -0.26 | -0.37 | -0.21 | -0.15 | -0.15 |
2020-12-31 | -0.37 | -0.69 | -0.21 | 0.21 | -0.15 |
2020-09-30 | -0.36 | -0.64 | -0.29 | 0.29 | -0.21 |
2020-06-30 | -0.36 | -0.59 | -0.31 | 0.37 | -0.23 |
Gross Margins
- marjin kotor untuk SI-BONE, Inc. pada 2025 Jun 30 adalah 0.79.
- marjin bersih untuk SI-BONE, Inc. pada 2025 Jun 30 adalah -0.15.
- marjin operasi untuk SI-BONE, Inc. pada 2025 Jun 30 adalah -0.17.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.79 | -0.15 | -0.17 |
2025-03-31 | 0.79 | -0.18 | -0.21 |
2024-12-31 | 0.78 | -0.24 | -0.27 |
2024-09-30 | 0.78 | -0.27 | -0.30 |
2024-06-30 | 0.78 | -0.30 | -0.33 |
2024-03-31 | 0.79 | -0.31 | -0.34 |
2023-12-31 | 0.82 | -0.33 | -0.35 |
2023-09-30 | 0.83 | -0.38 | -0.39 |
2023-06-30 | 0.84 | -0.38 | -0.39 |
2023-03-31 | 0.85 | -0.47 | -0.46 |
2022-12-31 | 0.86 | -0.65 | -0.62 |
2022-09-30 | 0.87 | -0.65 | -0.62 |
2022-06-30 | 0.88 | -0.69 | -0.65 |
2022-03-31 | 0.88 | -0.67 | -0.62 |
2021-12-31 | 0.89 | -0.63 | -0.57 |
2021-09-30 | 0.89 | -0.59 | -0.53 |
2021-06-30 | 0.89 | -0.52 | -0.49 |
2021-03-31 | 0.88 | -0.56 | -0.50 |
2020-12-31 | 0.88 | -0.60 | -0.53 |
2020-09-30 | 0.88 | -0.62 | -0.55 |
2020-06-30 | 0.88 | -0.68 | -0.58 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1459839 |
Grupong Pang-industriya
SIC 3841 - Surgical and Medical Instruments and Apparatus |